| First Author | Schönke M | Year | 2018 |
| Journal | J Lipid Res | Volume | 59 |
| Issue | 7 | Pages | 1276-1282 |
| PubMed ID | 29739863 | Mgi Jnum | J:265362 |
| Mgi Id | MGI:6188752 | Doi | 10.1194/jlr.D082370 |
| Citation | Schonke M, et al. (2018) Effects of high-fat diet and AMP-activated protein kinase modulation on the regulation of whole-body lipid metabolism. J Lipid Res 59(7):1276-1282 |
| abstractText | Metabolic flexibility, the capacity to adapt to fuel availability for energy production, is crucial for maintaining whole-body energy homeostasis. An inability to adequately promote FA utilization is associated with lipid accumulation in peripheral tissues and contributes to the development of insulin resistance. In vivo assays to quantify whole-body lipid oxidation in mouse models of insulin resistance are lacking. We describe a method for assessing whole-body FA oxidation in vivo, as well as tissue-specific lipid uptake in conscious mice. The method relies on intravenous administration of [9,10-(3)H(N)]palmitic acid combined with a non-beta-oxidizable palmitate analog, [1-(14)C]2-bromopalmitic acid. Pretreatment with etomoxir, a CPT1 inhibitor that prevents the shuttling of FAs into mitochondria, markedly reduced the appearance of the beta-oxidation product (3)H2O in circulation and reduced lipid uptake by oxidative tissues including heart and soleus muscle. Whole-body fatty oxidation was unaltered between chow- or high-fat-fed WT and transgenic mice expressing a mutant form of the AMPK gamma3 subunit (AMPKgamma3(R225Q)) in skeletal muscle. High-fat feeding increased lipid oxidation in WT and AMPKgamma3(R225Q) transgenic mice. In conclusion, this technique allows for the assessment of the effect of pharmaceutical agents, as well as gene mutations, on whole-body FA oxidation in mice. |
